Literature DB >> 35139431

Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia.

Mariangela Scarduzio1, Ellen J Hess2, David G Standaert3, Karen L Eskow Jaunarajs4.   

Abstract

This review provides an overview of the synaptic dysfunctions of neuronal circuits and underlying neurochemical alterations observed in the hyperkinetic movement disorders, dystonia and dyskinesia. These disorders exhibit similar changes in expression of synaptic plasticity and neuromodulation. This includes alterations in physical attributes of synapses, synaptic protein expression, and neurotransmitter systems, such as glutamate and gamma-aminobutyric acid (GABA), and neuromodulators, such as dopamine, acetylcholine, serotonin, adenosine, and endocannabinoids. A full understanding of the mechanisms and consequences of disruptions in synaptic function and plasticity will lend insight into the development of these disorders and new ways to combat maladaptive changes.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Basal ganglia; Dystonia; L-DOPA-induced dyskinesia; Neurotransmitters; Parkinson's disease; Receptors; Striatum; Synaptic dysfunction; Synaptic plasticity

Mesh:

Substances:

Year:  2022        PMID: 35139431     DOI: 10.1016/j.nbd.2022.105650

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  1 in total

1.  Discovery of levodopa-induced dyskinesia-associated genes using genomic studies in patients and Drosophila behavioral analyses.

Authors:  Woongchang Yoon; Soohong Min; Ho-Sung Ryu; Sun Ju Chung; Jongkyeong Chung
Journal:  Commun Biol       Date:  2022-08-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.